Statin Use and Risk of Cognitive Decline in the ADNI Cohort
The 2013 American College of Cardiology and American Heart Association practice guidelines recommend physicians prescribe HMG-CoA reductase inhibitors (statins) to patients with high cholesterol and to patients with or at high risk for atherosclerotic cardiovascular disease, regardless of cholesterol levels1. According to the National Center for Health Statistics (NCHS), from 2011 to 2012, 1 in 4 adults ages 40 years and older were taking prescription cholesterol lowering medications, 93% of which were statins2.
Source: The American Journal of Geriatric Psychiatry - Category: Geriatrics Authors: Emily C. Kemp, Megan K. Ebner, Srinath Ramanan, Tyler A. Godek, Erika A. Pugh, Hugh H. Bartlett, Julia W. McDonald, Marcia C. Mecca, Christopher H. van Dyck, Adam P. Mecca, the Alzheimer's Disease Neuroimaging Initiative Tags: Regular Research Article Source Type: research
More News: Alzheimer's | Brain | Cardiology | Cardiovascular | Cholesterol | Geriatrics | Heart | Neurology | Psychiatry | Statin Therapy | Statistics